Jeff Reeves

Jeff Reeves is a financial commentator with almost two decades of newsroom and markets experience, including a stint as an editor for the New York Times Co. He has been lead writer and editor for InvestorPlace.com since the beginning of 2010.

Jeff’s work has appeared in numerous finance publications and broadcast outlets, including The Wall Street Journal network, CNBC, TheStreet.com, Fox Business Channel, USA Today and a host of others.

View some of his TV appearances on YouTube, or check out his writing links below.

Jeff has also penned an eBook, The Frugal Investor’s Guide to Finding Great Stocks: 11 Free Resources to Help Beginners Identify Fantastic Investments.

Write Jeff at editor@investorplace.com, or follow him on Twitter @JeffReevesIP.

Recent Articles

NYSE:DPS – Is Dr. Pepper Snapple Stock a Buy or a Sell?

By Jeff Reeves Apr 28, 2016

Dr. Pepper Snapple Group (NYSE:DPS) isn't the first soda company most investors think of. But it should be after DPS stock results lately.

9 Best Cheap Stocks to Buy Now Under $9.99

By Jeff Reeves Apr 19, 2016

This list of nine best cheap stocks to buy now focuses on more than low price -- these companies either offer value, or a chance to catch the momentum train.

Tesla Motors Inc (TSLA) at a Crossroads: 3 Pros, 3 Cons

By Jeff Reeves Apr 18, 2016

Tesla Motors Inc has been on a tear since February, powered mostly by the hype and reveal of the Model 3. But can the run in TSLA stock last?

10 Best Stocks In the S&P 500 So Far

By Jeff Reeves Mar 30, 2016

Some gains look sustainable, others can't last, but these are the best stocks in the S&P 500 so far in 2016.

SPDR S&P Biotech (ETF) (XBI) – The Best Biotech Investment Now

By Jeff Reeves Mar 24, 2016

The best biotech stocks are hard to identify, but the XBI ETF allows investors to make a diversified but aggressive bet on small, high-growth biotech stocks.